Form 8-K - Current report:
SEC Accession No. 0001628280-23-022681
Filing Date
2023-06-20
Accepted
2023-06-20 16:05:08
Documents
15
Period of Report
2023-06-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20230615.htm   iXBRL 8-K 43858
2 EX-3.1 certificateofamendment6-16.htm EX-3.1 11821
7 ardx-20230615_g1.jpg GRAPHIC 2570
  Complete submission text file 0001628280-23-022681.txt   235581

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20230615.xsd EX-101.SCH 2155
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20230615_def.xml EX-101.DEF 15800
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20230615_lab.xml EX-101.LAB 30723
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20230615_pre.xml EX-101.PRE 16517
9 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20230615_htm.xml XML 4956
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 231024997
SIC: 2834 Pharmaceutical Preparations